Skip to main content

Advertisement

SpringerLink
Log in

Infliximab in rheumatoid arthritis

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Klareskog L, van der Heijde D, de Jager JP, et al.: Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomized controlled trial. Lancet 2004, 363:675–681.

    Article  PubMed  CAS  Google Scholar 

  2. Keystone EC, Kavanaugh AF, Sharp JT, et al.: Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy. A randomized, placebo-controlled, 52-week trial. Arthritis Rheum 2004, 50:1400–1411.

    Article  PubMed  CAS  Google Scholar 

  3. Maini RN, Breedveld FC, Kalden JR, et al.: Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 2004, 50:1051- 1065.

    Article  PubMed  CAS  Google Scholar 

  4. Bathon JM, Martin RW, Fleischmann RM, et al.: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000, 343:1586- 1593.

    Article  PubMed  CAS  Google Scholar 

  5. Moreland LW, Schiff MH, Baumgartner SW, et al.: Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial. Ann Intern Med 1999, 130:478- 486.

    PubMed  CAS  Google Scholar 

  6. Winblatt ME, Keystone EC, Furst DE, et al.: Adalimumab, a fully human anti-tumor necrosis factor á monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003, 48:35- 45.

    Article  Google Scholar 

  7. Maini RN, Breedveld FC, Kalden JR, et al.: Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998, 41:1552- 1563.

    Article  PubMed  CAS  Google Scholar 

  8. Lipsky PE, van der Heijde D, St Clair WF, et al.: Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000, 343:1594- 1602.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Larry Moreland MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreland, L. Infliximab in rheumatoid arthritis. Curr Rheumatol Rep 6, 334–335 (2004). https://doi.org/10.1007/s11926-004-0006-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-004-0006-3

Keywords

Search

Navigation